Kubo Hiroshi
Department of Advanced Preventive Medicine for Infectious Disease, Tohoku University Graduate School of Medicine.
Nihon Rinsho. 2011 Oct;69(10):1869-72.
No treatment to cure of chronic obstructive pulmonary disease (COPD) is available. Regenerative medicine is one of promising areas for this intractable disease. Several reagents and growth factors are known to promote lung regeneration in small animal models. However, regenerative medicines for human lungs are not achieved yet. Recent advances in stem cell biology and tissue engineering have expanded our understanding of lung endogenous stem cells, and this new knowledge provides us with new ideas for future regenerative therapy for lung diseases. Although lungs are the most challenging organ for regenerative medicine, our cumulative knowledge of lung regeneration and of endogenous progenitor cells makes clear the possibilities for regenerative approach to COPD.
目前尚无治愈慢性阻塞性肺疾病(COPD)的疗法。再生医学是治疗这种难治性疾病的一个有前景的领域。已知几种试剂和生长因子可促进小动物模型中的肺再生。然而,用于人类肺部的再生药物尚未实现。干细胞生物学和组织工程学的最新进展扩展了我们对肺内源性干细胞的认识,这一新知识为未来肺部疾病的再生治疗提供了新思路。尽管肺是再生医学中最具挑战性的器官,但我们对肺再生和内源性祖细胞的积累知识明确了COPD再生方法的可能性。